Suscribirse

Neurological involvement in Behçet’s disease: 154 cases from a cohort of 925 patients and a review of the literature - 06/05/08

Doi : RN-11-2006-162-11-0035-3787-101019-200608993 

S Benamour,

T Naji,

FZ Alaoui,

H El Kabli,

S El Aidouni

Ver las filiaciones

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Neurological involvement in Behçet’s disease (BD) is well recognised with a prevalence of 5.3 to 30 per cent. The purpose of this retrospective study was to analyse the clinical patterns of neuro-Behçet’s (NB) and to compare them with features of 925 NBs recorded in the literature during the same period.

All patients with NB fulfilled the International Study Group criteria for the diagnosis. Ninety-three patients with headache alone were excluded. Clinical findings were complemented by CSF studies, CT and MRI scanning and angiography.

NB was present in 16.4 per cent of BD patients. The male: female ratio was 4: 3. The mean age of NB patients was 31.76 years; the average age at onset was 29.83 years; and the mean duration was 3.81 years. The clinical features were categorised into 2 major types: those with and without parenchymal involvement. Some patients had mixed features. Ninety four patients (61.03 per cent) presented with parenchymal central nervous system (CNS) involvement. The most common findings were pyramidal signs, cranial nerve palsies, a pseudo-bulbar syndrome and cerebellar signs. Twenty seven patients (17.53 per cent) without parenchymal involvement were divided into: a) those with intracranial hypertension - 24 patients (15.58 percent) - presenting with headache, vomiting and bilateral papilloedema; b) those with cerebral arterial involvement - 3 cases, one with cerebral aneurysms. A mixed pattern was found in 9 patients. Erythema nodosum and vascular involvement were more frequently found with intracranial hypertension than in BD without neurological involvement.

Other clinical features that were reported included a pure meningeal pattern in 15 cases, a pure peripheral neuropathy in 4 cases, isolated cranial nerve palsies in 8 cases, chorea in 1 patient and pseudo-tumor of the cervical cord in another. Six cases of juvenile BD and 1 instance of familial BD were found.

One hundred and thirty three patients were treated (86.36 per cent). The mean duration of treatment was 7.46 months. Corticosteroids, immunosuppressive agents (cyclophosphamide, azathioprine, chlorambucil) and anticoagulants (in intracranial hypertension) were used.

The course of the disease was favourable in only 54.13 per cent of cases and poor in 18.79 percent.

The paper concludes that NB occurrs frequently in men and and is more severe, especially when there is parenchymal involvement. 7 deaths were recorded of which 6 had the parenchymal form of the disease.

19 references.


Esquema



© 2006 Elsevier Masson SAS. Tous droits réservés.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 162 - N° 11

P. 1084-1090 - novembre 2006 Regresar al número

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.